News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

GLP-1 RAs may improve survival in cancer patients
27 May 2026
byStephen Padilla
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with diabetes and cancer results in significantly reduced mortality and hospitalizations relative to treatment with metformin, a study has shown.








